Christopher H. Price

Christopher H. Price

Directeur/Membre du Conseil chez Otothera Corp.

Health Technology
Process Industries
Finance

Profil

Christopher H.
Price
is a Director of AudioFusion, Inc. He is a Leader of Pharmaceuticals and Biotechnology for Liquidia Technologies, Inc. He is a Director of Otothera, Inc. He is a Member of the Scientific and Clinical Advisory Board of The Endpoint Group and ConjuGate, Inc. He is Chief Executive Officer of LAAMScience, Inc. Prior to joining LAAMScience, Dr. Price founded Larex, Inc. and served as President and Chief Executive Officer.
Before Larex, Dr. Price was a Principal of Medical Innovation Partners.
Previously, he was President and Chief Executive Officer of Nobex Corp.
He began his business career at Nova Pharmaceutical Corp.
as Vice President of Business Development.
He has more than 20 years of senior executive R&D, business development, and management experience in biotechnology, pharmaceuticals, medical devices, and specialty chemicals.
Dr. Price received a PhD in Biology from Syracuse University and an MBA from the Massachusetts Institute of Technology.

Postes actifs de Christopher H. Price

SociétésPosteDébut
Directeur/Membre du Conseil -
Tous les postes actifs de Christopher H. Price

Anciens postes connus de Christopher H. Price

SociétésPosteFin
Nova Pharmaceutical Corp. Corporate Officer/Principal -
President -
Directeur Général -
Corporate Officer/Principal -
President -
Voir l'expérience en détail de Christopher H. Price

Formation de Christopher H. Price

Massachusetts Institute of Technology Masters Business Admin
Syracuse University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher H. Price

Relations

6

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées6

Health Technology

Process Industries

Health Technology

Health Technology

Retail Trade

Nova Pharmaceutical Corp.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Christopher H. Price